Tirzepatide is ideal for adults with overweight or obesity who have struggled to achieve results through diet and exercise alone, particularly those with conditions like diabetes or high blood pressure
A randomized study investigating the effect of omeprazole on the pharmacokinetics of oral semaglutide
As a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist (RA), tirzepatide produces synergistic effects like increased insulin production and release, which gives it an edge over strict GLP-1 receptor agonist such as semaglutide (Ozempic)
Persistent or Worsening Symptoms : If symptoms continue to get worse over time, this might be a sign of an interaction or another health issue
Recommended reading: [1] Chavarro, Willett & Skerrett
Tirzepatide medications stimulate the production of both the GLP-1 hormone and the GIP hormone (glucosedependent insulinotropic polypeptide), which break down insulin and suppress appetite